Trevena

Trevena Debt

The Debt of Trevena (TRVN) as of Nov 20, 2026 is 36.25 M USD. In the previous year, Debt was 19.77 M USD — a change of 83.38% (higher).

Debt

36.25 MUSD

YoY

83.38%

Last updated:

In 2023, Trevena's total debt was 36.25 M USD, a 83.38% change from the 19.77 M USD total debt recorded in the previous year.

The Trevena Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt
Date
Debt
Jan 1, 2016
18.33 M USD
Jan 1, 2017
28.18 M USD
Jan 1, 2018
17.39 M USD
Jan 1, 2019
13.46 M USD
Jan 1, 2020
7.80 M USD
Jan 1, 2021
7.10 M USD
Jan 1, 2022
19.77 M USD
Jan 1, 2023
36.25 M USD
The Trevena Debt history
YEARDebtYoY
36.25 MUSD+83.38%
19.77 MUSD+178.34%
7.10 MUSD-9.01%
7.80 MUSD-42.03%
13.46 MUSD-22.61%
17.39 MUSD-38.28%
28.18 MUSD+53.77%
18.33 MUSD-49.63%
36.39 MUSD+938.01%
3.51 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Trevena Stock analysis

What does Trevena do? Trevena, Inc. develops and commercializes novel medicines for central nervous system disorders, focusing on OLINVO for moderate-to-severe acute pain management in hospitals and ambulatory surgery centers. The company commercializes OLINVO in the United States under its own brand, targeting healthcare providers in acute care settings. TRV250, a non-narcotic migraine treatment with potential for other CNS indications, is in Phase I development in the United Kingdom, with the company advancing its research through its ABLE product platform. Trevena leverages its ABLE platform to identify GPCR-targeted biased ligands, supporting its pipeline development without external partnerships or third-party sales. The company generates revenue through the commercialization of OLINVO in the U.S. acute care market, with healthcare facilities and providers as primary buyers. TRV250 remains in development, with no current sales, but the company anticipates future revenue once it progresses through clinical trials. Trevena’s ABLE platform serves as a foundational asset for discovering new compounds, reducing reliance on external licensing or collaborations. Its focus on G protein pathway selective modulators and biased ligands differentiates its product portfolio in CNS therapeutics. Trevena is one of the most popular companies on Eulerpool.

Debt Details

Understanding Trevena's Debt Structure

Trevena's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Trevena's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Trevena’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Trevena’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Trevena stock

Debt of Trevena is 36.25 M USD in 2023.

Debt of Trevena changed from 19.77 M USD to 36.25 M USD, representing a 83.38% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Debt Trevena since 2006 – with annual values, charts, and detailed analysis.

Debt's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Debt's Trevena historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Trevena

All Key Metrics — Trevena